SunWay Biotech Co (ROCO:1271) ROCE % : 0.30% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SunWay Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SunWay Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.30%.

SunWay Biotech Co ROCE % Historical Data

The historical data trend for SunWay Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SunWay Biotech Co ROCE % Chart

SunWay Biotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

14.30

33.76

33.67

9.73

3.01

SunWay Biotech Co Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial					39.01	30.40	-19.80	20.40	0.30

SunWay Biotech Co ROCE % Calculation

SunWay Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	56.362	/	( ( (478.228 - 187.096)	+	(3655.459 - 203.398) )	/ 2 )
	=	56.362	/	( (291.132	+	3452.061)	/ 2 )
	=	56.362	/	1871.5965
	=	3.01 %

SunWay Biotech Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	6.312	/	( ( (835.811 - 83.539)	+	(3655.459 - 203.398) )	/ 2 )
	=	6.312	/	( ( 752.272	+	3452.061 )	/ 2 )
	=	6.312	/	2102.1665
	=	0.30 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

SunWay Biotech Co (ROCO:1271) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SunWay Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of SunWay Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SunWay Biotech Co (ROCO:1271) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » SunWay Biotech Co Ltd (ROCO:1271) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494

Website

http://www.sunway.cc

SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.

SunWay Biotech Co (ROCO:1271) Headlines

No Headlines